Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer

Acta Radiologica

Volumn 52, Issue 9, 2011, Pages 1009-1014

  Hahn, Steffen ^a   Heusner, Till ^a   Kümmel, Sherko ^a   Ninger, Angelika Kö ^a   Nagarajah, James ^a   Müller, Stefan ^a   Boy, Christian ^a   Forsting, Michael ^a   Bockisch, Andreas ^a   Antoch, Gerald ^a   Stahl, Alexander ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Breast; Metastases; Molecular imaging; MR imaging; Staging

Indexed keywords

BREAST; METASTASES; MOLECULAR IMAGING; MR IMAGING; STAGING;

DISEASES; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; NUCLEAR MEDICINE; PATHOLOGY; STANDARDS;

BONE;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE; BONE TUMOR; BREAST TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

ADULT; AGED; BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 83155165168     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.100507     Document Type: Article

References (19)

1. Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009;36:1543-50
2. Heusner TA, Kuemmel S, Umutlu L, et al. Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med 2008;49:1215-22
3. Du Y, Cullum I, Illidge TM, et al. Fusion of metabolic function and morphology: sequential (18F) fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol 2007;25:3440-7 (Pubitemid 47310881)
4. Heusner TA, Freudenberg LS, Kuehl H, et al. Whole-body PET/CT-mammography for staging breast cancer: initial results. Br J Radiol 2008;81:743-8
5. Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 1983;23:175-80 (Pubitemid 13035296)
6. Shie P, Cardarelli R, Brandon D, et al. Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer. Clin Nucl Med 2008;33:97-101
7. Kao CH, Hsieh JF, Tsai SC, et al. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 2000;20:2189-92
8. Nakai T, Okuyama C, Kubota T, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 2005;32:1253-8 (Pubitemid 41598715)
9. Kreienberg R, Kopp I, Lorenz W, et al. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Munich: W Zuckschwerdt Verlag GmbH, 2008
10. Antoch G, Kuehl H, Kanja J, et al. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 2004;230:879-85 (Pubitemid 38252890)
11. Dose J, Bleckmann C, Bachmann S, et al. Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients. Nucl Med Commun 2002;23:857-64
12. Mahner S, Schirrmacher S, Brenner W, et al. Comparison between positron emission tomography using 2-(fluorine-18) fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann Oncol 2008;19:1249-54 (Pubitemid 351911953)
13. Liu T, Cheng T, Xu W, et al. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol 2011;40:523-31
14. Gallowitsch HJ, Kresnik E, Gasser J, et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 2003;38:250-6 (Pubitemid 36535030)
15. Fueger BJ, Weber WA, Quon A, et al. Performance of 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol 2005;7:369-76 (Pubitemid 44193414)
16. Morris PG, Lynch C, Feeney JN, et al. Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. J Clin Oncol 2010;28:3154-9
17. Veit-Haibach P, Antoch G, Beyer T, et al. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. Br J Radiol 2007;80:508-15 (Pubitemid 47343078)
18. Nakamoto Y, Cohade C, Tatsumi M, et al. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Radiology 2005;237:627-34 (Pubitemid 41507904)
19. Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 2009;10:606-14